<p>(A–D) Cytokine production by peptide-specific CD4 T cells. DR1 (A and B) and B10 (C and D) mice were infected intranasally with 40,000 EID<sub>50</sub> NC. Enriched CD4 T cells from the MedLN and spleen were analyzed on day 10 after infection. Frequencies of CD4 T cells secreting IL-2, IFN-γ, or IL-4 were determined by ELISpot assay after in vitro stimulation with antigen-presenting cells and individual 17-mer peptides. Peptide designations (x-axis) include the viral proteins of origin (HA, NA, NP, M1, and NS1). <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0034377#s3" target="_blank">Results</a> are normalized to spot counts per 10<sup>6</sup> CD4 T cells and are shown as the mean+SEM for 2–6 independent experime...
<p>(A–C) Mice were primed with Env-CN54 gp140 in combination with either alum alone or a medium (“me...
<div><p>Human CD4 T cell recall responses to influenza virus are strongly biased towards Type 1 cyto...
<p>CB6F1 mice (N = 40/group) were immunized intramuscularly with two administrations (2 weeks apart)...
<p>(A, B) Cytokine production by peptide-specific CD4 T cells. DR1 and B10 mice were infected intran...
<p>(A–D) Virus-specific ASC frequencies. DR1 (A and B) and B10 (C and D) mice were immunized intramu...
<p>A: CD4+ T-cells were isolated from spleens of mice immunized with single peptides as indicated. T...
<p>Responses of splenocytes from CD46/IFNAR mice immunised with 10<sup>4</sup>–10<sup>7</sup> TCID<s...
<p>Mice were infected and immunized as depicted in <a href="http://www.plosone.org/article/info:doi/...
<p>The spleens were dissected and pooled on day 35 from groups of four mice immunized with vaccine c...
<p>Splenic CD4 and CD8 T cells producing TNF-α, IL-2, or IFN-γ in response to p24(65–73) or p24(10–3...
<p>Mice (n = 4 per group) were immunized with either pDV13-ED3 or pDV24-ED3 and boosted with recombi...
<p>CB6F1 mice were vaccinated once with Ad-H4, twice with rH4 in cationic liposomes, or once with rH...
<p>(A) Representative dot plot of CD4<sup>+</sup> T cells expressing IL-2 and IL-4 after stimulation...
<p>At 60-days post anti-CD20 mono- (MT, open bars) or combination therapy (CT, filled black bars), C...
Human CD4 T cell recall responses to influenza virus are strongly biased towards Type 1 cytokines, p...
<p>(A–C) Mice were primed with Env-CN54 gp140 in combination with either alum alone or a medium (“me...
<div><p>Human CD4 T cell recall responses to influenza virus are strongly biased towards Type 1 cyto...
<p>CB6F1 mice (N = 40/group) were immunized intramuscularly with two administrations (2 weeks apart)...
<p>(A, B) Cytokine production by peptide-specific CD4 T cells. DR1 and B10 mice were infected intran...
<p>(A–D) Virus-specific ASC frequencies. DR1 (A and B) and B10 (C and D) mice were immunized intramu...
<p>A: CD4+ T-cells were isolated from spleens of mice immunized with single peptides as indicated. T...
<p>Responses of splenocytes from CD46/IFNAR mice immunised with 10<sup>4</sup>–10<sup>7</sup> TCID<s...
<p>Mice were infected and immunized as depicted in <a href="http://www.plosone.org/article/info:doi/...
<p>The spleens were dissected and pooled on day 35 from groups of four mice immunized with vaccine c...
<p>Splenic CD4 and CD8 T cells producing TNF-α, IL-2, or IFN-γ in response to p24(65–73) or p24(10–3...
<p>Mice (n = 4 per group) were immunized with either pDV13-ED3 or pDV24-ED3 and boosted with recombi...
<p>CB6F1 mice were vaccinated once with Ad-H4, twice with rH4 in cationic liposomes, or once with rH...
<p>(A) Representative dot plot of CD4<sup>+</sup> T cells expressing IL-2 and IL-4 after stimulation...
<p>At 60-days post anti-CD20 mono- (MT, open bars) or combination therapy (CT, filled black bars), C...
Human CD4 T cell recall responses to influenza virus are strongly biased towards Type 1 cytokines, p...
<p>(A–C) Mice were primed with Env-CN54 gp140 in combination with either alum alone or a medium (“me...
<div><p>Human CD4 T cell recall responses to influenza virus are strongly biased towards Type 1 cyto...
<p>CB6F1 mice (N = 40/group) were immunized intramuscularly with two administrations (2 weeks apart)...